Timing is everything: new trial challenges standard wait for pancreatitis procedure
NCT ID NCT07406698
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares early versus delayed endoscopic drainage in patients with infected necrotizing pancreatitis. About 104 adults with symptomatic, infected pancreatic fluid collections will be randomly assigned to receive the procedure within 4 weeks of disease onset or after the standard 4-week waiting period. The goal is to see if early intervention reduces major complications or death.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
endoscopic drainage procedure
What this could lead to
If early intervention proves better, it could reduce complications and deaths from infected pancreatic necrosis and shorten hospital stays.
What could go wrong
This is a relatively small trial (104 participants) and early drainage may carry risks like bleeding or infection. Results may not apply to all patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATITIS, ACUTE NECROTIZING are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Orlando Health Digestive Health Institute
RECRUITINGOrlando, Florida, 32806, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••